CUA:成本效用分析
成本效用分析(Cost-Utility Analysis,简称CUA)是一种广泛运用于医学与卫生经济学领域的评估方法,主要用于衡量不同治疗方案的经济效益与健康产出之间的关系。该术语在英国等国家的医疗决策体系中尤为常见,其缩写CUA便于在学术文献和实际应用中快速书写与交流。通过将健康结果转化为效用值(如质量调整生命年QALYs),CUA能够系统比较医疗干预措施的成本与效果,为资源分配提供科学依据。
Cost-Utility Analysis具体释义
Cost-Utility Analysis的英文发音
例句
- Uncertainty Analysis of Markov Process to the Cost-utility Analysis of Medical Intervention Measures
- 医学干预措施成本效用马尔可夫模型的不确定性分析
- Second, it focuses on the need of cost-utility analysis of administrative legislation in our country.
- 其次,重点介绍了我国进行行政立法成本&效益分析的必要性。
- Methods : Cost-utility analysis was performed by using quality-adjusted life year ( QALY ) as the index of utility.
- 方法:以质量调整生命年(Quality-adjustedLifeYear,QALY)为效用指标进行成本效用分析(CUA)。
- Methods Three major techniques of medical economics namely cost-effective analysis ( CEA ), cost-benefit analysis ( CBA ) and cost-utility analysis ( CUA ) were used to assess the screening program.
- 方法采用了三种基本的卫生经济学评价方法:成本-效果分析(CEA)、成本-效益分析(CBA)和成本-效用分析(CUA)。
- BACKGROUND AND OBJECTIVE : As one method of pharmacoeconomics evaluation, cost-utility analysis has comparability for that its utility combines quality and quantity, and has a great prospect for development, and its development in foreign countries is becoming increasingly popular.
- 背景与目的:成本效用分析(CUA)作为药物经济学研究的方法之一,由于其测量的效用具有可比性,而且综合了质量和数量,具有很大的发展前景,在国外的发展也正日益普遍。
本站英语缩略词为个人收集整理,可供非商业用途的复制、使用及分享,但严禁任何形式的采集或批量盗用
若CUA词条信息存在错误、不当之处或涉及侵权,请及时联系我们处理:675289112@qq.com。